REPORT ID 3249

Global Chagas Disease Drug Market Research Report 2017

Publish Date
13-Dec-17
Pages
112
Format
Electronic (PDF)

In this report, the global Chagas Disease Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Chagas Disease Drug in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Chagas Disease Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    AstraZeneca Plc
    Bayer AG
    Daiichi Sankyo Co Ltd
    Eisai Co Ltd
    GlaxoSmithKline Plc
    Grupo Praxis Pharmaceutical SA
    Humanigen Inc
    Kancera AB
    Merck & Co Inc
    Novartis AG
    Oblita Therapeutics BVBA
    Sanofi
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Cz-007
    Cz-008
    D-121
    DNDI-0690
    EPLBS-1246
    EPLBS-967
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospital
    Clinic
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Chagas Disease Drug Market Research Report 2017
1 Chagas Disease Drug Market Overview
    1.1 Product Overview and Scope of Chagas Disease Drug
    1.2 Chagas Disease Drug Segment by Type (Product Category)
        1.2.1 Global Chagas Disease Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Chagas Disease Drug Production Market Share by Type (Product Category) in 2016
        1.2.3 Cz-007
        1.2.4 Cz-008
        1.2.5 D-121
        1.2.6 DNDI-0690
        1.2.7 EPLBS-1246
        1.2.8 EPLBS-967
        1.2.9 Others
    1.3 Global Chagas Disease Drug Segment by Application
        1.3.1 Chagas Disease Drug Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Global Chagas Disease Drug Market by Region (2012-2022)
        1.4.1 Global Chagas Disease Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Chagas Disease Drug (2012-2022)
        1.5.1 Global Chagas Disease Drug Revenue Status and Outlook (2012-2022)
        1.5.2 Global Chagas Disease Drug Capacity, Production Status and Outlook (2012-2022)

2 Global Chagas Disease Drug Market Competition by Manufacturers
    2.1 Global Chagas Disease Drug Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Chagas Disease Drug Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Chagas Disease Drug Production and Share by Manufacturers (2012-2017)
    2.2 Global Chagas Disease Drug Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Chagas Disease Drug Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Chagas Disease Drug Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Chagas Disease Drug Market Competitive Situation and Trends
        2.5.1 Chagas Disease Drug Market Concentration Rate
        2.5.2 Chagas Disease Drug Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Chagas Disease Drug Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Chagas Disease Drug Capacity and Market Share by Region (2012-2017)
    3.2 Global Chagas Disease Drug Production and Market Share by Region (2012-2017)
    3.3 Global Chagas Disease Drug Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Chagas Disease Drug Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Chagas Disease Drug Consumption by Region (2012-2017)
    4.2 North America Chagas Disease Drug Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Chagas Disease Drug Production, Consumption, Export, Import (2012-2017)
    4.4 China Chagas Disease Drug Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Chagas Disease Drug Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Chagas Disease Drug Production, Consumption, Export, Import (2012-2017)
    4.7 India Chagas Disease Drug Production, Consumption, Export, Import (2012-2017)

5 Global Chagas Disease Drug Production, Revenue (Value), Price Trend by Type
    5.1 Global Chagas Disease Drug Production and Market Share by Type (2012-2017)
    5.2 Global Chagas Disease Drug Revenue and Market Share by Type (2012-2017)
    5.3 Global Chagas Disease Drug Price by Type (2012-2017)
    5.4 Global Chagas Disease Drug Production Growth by Type (2012-2017)

6 Global Chagas Disease Drug Market Analysis by Application
    6.1 Global Chagas Disease Drug Consumption and Market Share by Application (2012-2017)
    6.2 Global Chagas Disease Drug Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Chagas Disease Drug Manufacturers Profiles/Analysis
    7.1 AstraZeneca Plc
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Chagas Disease Drug Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 AstraZeneca Plc Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Bayer AG
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Chagas Disease Drug Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Bayer AG Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Daiichi Sankyo Co Ltd
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Chagas Disease Drug Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Daiichi Sankyo Co Ltd Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Eisai Co Ltd
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Chagas Disease Drug Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Eisai Co Ltd Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 GlaxoSmithKline Plc
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Chagas Disease Drug Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 GlaxoSmithKline Plc Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Grupo Praxis Pharmaceutical SA
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Chagas Disease Drug Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Humanigen Inc
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Chagas Disease Drug Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Humanigen Inc Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Kancera AB
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Chagas Disease Drug Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Kancera AB Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Merck & Co Inc
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Chagas Disease Drug Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Merck & Co Inc Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Novartis AG
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Chagas Disease Drug Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Novartis AG Chagas Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Oblita Therapeutics BVBA
    7.12 Sanofi

8 Chagas Disease Drug Manufacturing Cost Analysis
    8.1 Chagas Disease Drug Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Chagas Disease Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Chagas Disease Drug Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Chagas Disease Drug Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Chagas Disease Drug Market Forecast (2017-2022)
    12.1 Global Chagas Disease Drug Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Chagas Disease Drug Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Chagas Disease Drug Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Chagas Disease Drug Price and Trend Forecast (2017-2022)
    12.2 Global Chagas Disease Drug Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Chagas Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Chagas Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Chagas Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Chagas Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Chagas Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Chagas Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Chagas Disease Drug Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Chagas Disease Drug Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer